APA (7th ed.) Citation

P, J., R, S., N, S., G, K., I, S., R, S., . . . IM, L. (2025). Long-Term Treatment With Subcutaneous Treprostinil in Patients With Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension in the Multimodal Therapy Era (Data From CTREPH Study Open Label Extension). Pulmonary circulation, 15(2), e70080. https://doi.org/10.1002/pul2.70080

Chicago Style (17th ed.) Citation

P, Jansa, Sadushi-Kolici R, Skoro-Sajer N, Kopec G, Simkova I, Steringer-Mascherbauer R, Salobir B, Lindner J, and Lang IM. "Long-Term Treatment With Subcutaneous Treprostinil in Patients With Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension in the Multimodal Therapy Era (Data From CTREPH Study Open Label Extension)." Pulmonary Circulation 15, no. 2 (2025): e70080. https://doi.org/10.1002/pul2.70080.

MLA (9th ed.) Citation

P, Jansa, et al. "Long-Term Treatment With Subcutaneous Treprostinil in Patients With Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension in the Multimodal Therapy Era (Data From CTREPH Study Open Label Extension)." Pulmonary Circulation, vol. 15, no. 2, 2025, p. e70080, https://doi.org/10.1002/pul2.70080.